2-((2-CARBOXYETHYL)THIO)NICOTINIC ACID, 95.0%, 500mg

Dimethyl 4-chloropyridine-2,6-dicarboxylate, 95.0%, 5g

1-[4-(pyridin-4-yl)phenyl]ethan-1-one, 95%, 2.5g

2-AMINO-N,N-DIMETHYL-4-NITROBENZAMIDE, 90.0%, 1g

BENZOYL FLUORIDE, 95%, 25g

3,5-Dibromosalicylic Acid>98.0%(T)500g

3',5'-Difluoroacetophenone>97.0%(GC)5g

Glycerol Dimethacrylate (mixture of 1,2- and 1,3-form) (stabilized with MEHQ)>90.0%(GC)25g

3-Methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoic acid, 95.0%, 5g

L-Azidonorleucine Hydrochloride>95.0%(T)250mg

GC capillary column ROTI®Cap-1701, 50 m, 0.32 mm, 0.25 µm, 1 Piece(s)

Z-Phenylalaninol, 98%, 10g

2-(1-methylindolin-5-yl)-2-(4-methylpiperazin-1-yl)ethan-1-amine, 95.0%, 1g